Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma
Abstract
No abstract available
Journal Articles
Hematological Oncology
Year : 2022
Elizabeth Bernardo : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-03561692
Submitted on : Tuesday, February 8, 2022-2:11:14 PM
Last modification on : Friday, March 24, 2023-2:53:25 PM
Long-term archiving on: Monday, May 9, 2022-7:45:07 PM
Dates and versions
Identifiers
- HAL Id : inserm-03561692 , version 1
- DOI : 10.1002/hon.2965
- PUBMED : 35044695
Cite
Clément Bailly, Thomas Carlier, Benoit Tessoulin, Thomas Gastinne, Françoise Kraeber‐bodere, et al.. Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma. Hematological Oncology, 2022, Online ahead of print. ⟨10.1002/hon.2965⟩. ⟨inserm-03561692⟩
Collections
29
View
18
Download